An Intervention Program to Control Diabetes

This study has been completed.
Sponsor:
Information provided by:
Abbott Nutrition
ClinicalTrials.gov Identifier:
NCT00543621
First received: October 12, 2007
Last updated: NA
Last verified: October 2007
History: No changes posted
  Purpose

Study to evaluate the effectiveness of a structured intervention to improve diabetes control.


Condition Intervention Phase
Diabetes Mellitus, Type 2
Other: daily enteral nutritional product and/or behavioral changes
Phase 4

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: An Intervention Program to Control Diabetes

Resource links provided by NLM:


Further study details as provided by Abbott Nutrition:

Primary Outcome Measures:
  • HbA1c, Fasting blood glucose,blood pressure, weight loss [ Time Frame: 24 weeks ]

Enrollment: 150
Study Start Date: May 2005
  Eligibility

Ages Eligible for Study:   18 Years to 70 Years
Genders Eligible for Study:   Both
Criteria

Inclusion Criteria:

  • informed consent
  • 18-70 adults
  • Type 2 Diabetes
  • Males and non-pregnant females

Exclusion Criteria:

  • Use of exogenous insulin for glucose control
  • Use of medications or supplements for weight loss
  • Advanced diabetes complications
  • Recent history of cardiovascular event
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00543621

Locations
China
Huandong Hospital
Shanghai, China
Sponsors and Collaborators
Abbott Nutrition
Investigators
Principal Investigator: Jianqin Sun, MD, MPH Clinical Nutrition Center, Huadong Hospital
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00543621     History of Changes
Other Study ID Numbers: Welltech Study
Study First Received: October 12, 2007
Last Updated: October 12, 2007
Health Authority: China: Ethics Committee

Additional relevant MeSH terms:
Diabetes Mellitus
Diabetes Mellitus, Type 2
Glucose Metabolism Disorders
Metabolic Diseases
Endocrine System Diseases

ClinicalTrials.gov processed this record on April 17, 2014